First Page | Document Content | |
---|---|---|
Date: 2009-05-16 00:00:00Antiemetics Chemotherapy-induced nausea and vomiting 5-HT3 antagonist Dolasetron Aprepitant Ondansetron Palonosetron Granisetron NK1 receptor antagonist Chemistry Medicine Organic chemistry | Overview of the updated antiemetic guidelines for chemotherapy-induced nausea and vomitingAdd to Reading ListSource URL: www.oncologypractice.comDownload Document from Source WebsiteFile Size: 165,24 KBShare Document on Facebook |
P11444 - ASCO2014 MEC and HECDocID: 1a4Ek - View Document | |
P11444 - ASCO2014 MEC and HECDocID: 19OCx - View Document | |
Astellas Receives Approval for a Supplemental New Drug Application for Irribow®/Irribow® OD, a Treatment of Diarrhea-predominant Irritable Bowel Syndrome, in Japan Tokyo, May 26, Astellas Pharma Inc. (“AstellaDocID: 19AF1 - View Document | |
P11444 - ASCO2014 MEC and HECDocID: 199Dl - View Document | |
P11444 - ASCO2014 MEC and HECDocID: 1987o - View Document |